ALLY
Ally Financial Inc.
ALLY's fundamentals are strong: its operating margin rose 11 points to 21% and revenue grew 12%. At 8.7x earnings, it's trading in line with its usual 9.4x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ALLY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
ALLY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALLY.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ALLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.4x | $23.66 | -38% |
| Forward | 6.5x | $38.00 | — |
| Current | 8.7x | $38.00 | — |
| Fair | 9.4x | $41.09 | +8.1% |
| Expensive | 17x | $75.07 | +98% |
Historical ranges are pointers, not guarantees.
ALLY's PE is in its fair range at 8.7x. If earnings grow as analysts expect, today's price would be 6.5x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ALLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
ALLY has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.85 | +34% |
| Q3 2026 | $4.38 | +164% |
| Q2 2026 | $4.26 | +177% |
| Q1 2026 | $4.12 | +203% |
| Q4 2025 | $2.37 | -8.8% |
| Q3 2025 | $1.66 | -33% |
| Q2 2025 | $1.54 | -33% |
| Q1 2025 | $1.36 | -44% |
| Q4 2024 | $2.60 | -13% |
ALLY has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ALLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +7.6% |
| Q2 2026 | $2.3B | +9.8% |
| Q1 2026 | $2.1B | +36% |
| Q4 2025 | $2.1B | +1.5% |
| Q3 2025 | $2.2B | +3.1% |
| Q2 2025 | $2.1B | +4.1% |
| Q1 2025 | $1.5B | -22% |
| Q4 2024 | $2.1B | +1.2% |
ALLY's revenue has grown year over year for six quarters in a row: $2.3B last quarter, up 7.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +0.6 points |
| Q2 2026 | 23% | +2.5 points |
| Q1 2026 | 19% | +38 points |
| Q4 2025 | 18% | +9.8 points |
| Q3 2025 | 24% | +13 points |
| Q2 2025 | 21% | +8.1 points |
| Q1 2025 | -18% | -27 points |
| Q4 2024 | 8.4% | +5.3 points |
ALLY has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ALLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +33% |
| Q2 2026 | $1.4B | +43% |
| Q1 2026 | $1.4B | +46% |
| Q4 2025 | $640M | -33% |
| Q3 2025 | $1.2B | +21% |
| Q2 2025 | $947M | -40% |
| Q1 2025 | $940M | -30% |
| Q4 2024 | $951M | +$968M |
ALLY has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ALLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -2.9M shares |
| 1 year | -1.8% | -5.7M shares |
| 3 years | +0.8% | +2.4M shares |
| 5 years | -15% | -53.7M shares |
| Available history | -22% | -87.3M shares |
ALLY has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $178M |
| Q2 2026 | $148M |
| Q1 2026 | $147M |
| Q4 2025 | $23M |
| Q3 2025 | $1M |
| Q2 2025 | $1M |
| Q1 2025 | $34M |
| Q4 2024 | $7M |
ALLY spent $496M buying back its own shares over the past year, more than ten times what it spent the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ALLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.1x | High |
| Q2 2026 | 4.6x | High |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 4.8x | High |
| Q1 2025 | 5.6x | High |
| Q4 2024 | 4.2x | High |
ALLY's net debt is about 5.1 years of its operating earnings (EBITDA), up from 4.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ALLY.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ALLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.2 | Neutral |
| Stochastic | 21.5 | Neutral |
ALLY's weekly RSI is 39 (neutral) and its Stochastic is 21 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ALLY PE vs Financial Services Sector
| Metric | ALLY | Sector median | Relative |
|---|---|---|---|
| PE | 8.7x | 13x | 33% below |
| PE % | 44 | 63 | 19 pts below |
ALLY is trading at 8.7x earnings, a 33% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ALLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.2 | 0.4% below |
| 20 week MA | $41.4 | 8.2% below |
| 50 week MA | $42.1 | 9.8% below |
| 100 week MA | $39.8 | 4.6% below |
| 200 week MA | $36.5 | 4.2% above |
ALLY has fallen below most of its moving averages, though it's still 4.2% above its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ALLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.6 | $34.5 | +13% |
| 2021 | $34.5 | $47.6 | +38% |
| 2022 | $47.6 | $23.9 | -50% |
| 2023 | $23.9 | $34.9 | +46% |
| 2024 | $34.9 | $35.7 | +2.1% |
| 2025 | $35.7 | $46.3 | +30% |
| 2026 YTD | $46.3 | $38.0 | -18% |
ALLY has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.